chartexchange

ONCY
Oncolytics Biotech, Inc. Common Shares
stockNASDAQ

At CloseNov 18, 2026 3:59:57 PM EST
0.43USD+12.680%(+0.05)2,181,572
Pre-marketNov 18, 2026 9:26:30 AM EST
0.3927USD+2.667%(+0.0102)
After-hoursNov 18, 2026 4:44:30 PM EST
0.425USD-1.392%(-0.006)
Loading…
Loading…
Healthcare
Biotechnology
HQ
Calgary, AB, Canada
Previous Close
$0.38
Beta
1.23
52-Week High
$1.30 2026-01-22
52-Week Low
$0.33 2026-11-17
SMA 50
$0.56
SMA 200
$0.82
Avg. Vol 10D
1.24M
Avg. Vol 30D
1.30M
Avg. Vol 90D
1.08M
Relative Vol
1.68
136.14M
116.90M
11.0300%
31,589
ONCY Profile

oncolytics biotech is a biotechnology company focused on the development of oncolytic viruses as potential therapeutics for use in a broad range of cancers. the company is conducting clinical studies using reolysin®, its proprietary formulation of the human reovirus, in some of the most prevalent forms of the disease including lung, colorectal and pancreatic cancers. oncolytics' clinical program includes a number of human trials at a variety of stages including a phase iii trial in head and neck cancers. the company has advanced its product manufacturing and intellectual property initiatives in parallel with its clinical development program to support development of a commercial product.

ONCY Performance
PeriodPriceDateChangeBeta
1W0.412026-11-11+4.50%0.730
1M0.502026-10-19-13.34%-0.304
3M0.842026-08-18-49.09%-0.020
6M0.802026-05-18-46.24%0.653
1Y1.032025-11-18-58.24%1.233
2Y1.002024-11-18-56.77%—
5Y1.752021-11-18-75.42%0.917
ONCY Stock Summary

Oncolytics Biotech, Inc. Common Shares (NASDAQ:ONCY) stock price today is $0.43, and today's volume is 2,185,489. ONCY is up 12.444% today. The 30 day average volume is 1.30M. ONCY market cap is $58.55M with 136.14M shares outstanding.